CorMedix announced that for 2026, it expects revenue between $300 million and $320 million, compared to $310 million it reported in the full year 2025, according to preliminary data.
The first week of 2026 has delivered a definitive verdict on the next phase of the bull market: the era of mega-cap dominance is yielding to the rise of the small-cap. In a dramatic "Great Rotation," investors are pulling capital from the expensive, AI-saturated titans of the Nasdaq and pouring
The first trading week of 2026 has delivered a powerful resurgence of the "January Effect," with small-cap stocks staging a massive rally that has outpaced their mega-cap counterparts. As of January 6, 2026, the iShares Russell 2000 ETF (NYSE:IWM) has surged an impressive 6.2%, marking one of the
The opening days of 2026 have ushered in a definitive regime shift in the global financial markets, as the long-awaited "Great Rotation" finally takes hold. After years of dominance by a handful of mega-cap technology titans, investors are aggressively reallocating capital into the small-cap sector, propelling the Russell 2000 Index
Innodata operates as an AI enabler rather than a core AI platform, but is delivering strong revenue and EBITDA growth and guiding for 45%+ organic growth in 2025.
As the calendar turns to December 26, 2025, Wall Street is unwrapping a familiar gift: the "Santa Claus Rally." With the S&P 500 (NYSE: SPY) flirting with the psychological milestone of 7,000 points and hitting a record close of 6,920 just before the holiday break, investor optimism
As the final week of 2025 unfolds, the hallowed halls of the New York Stock Exchange and the digital corridors of the Nasdaq have transformed into a "ghost town." With many institutional traders having shuttered their desks for the season, the markets are grappling with a classic year-end phenomenon: the
Monday’s session brought a clear improvement in short-term breadth, with advancers firmly in control and the weekly breadth picture flipping back toward neutral/positive. Participation above key moving averages remains just above the 50% line? supportive, but not the kind of broad “all-oars-in-the-water” thrust that typically powers sustained breakouts.
Friday brought another constructive “repair” day after Thursday’s bounce: advancers stayed in control, 4% winners expanded, and new highs continued to outpace new lows. Still, the bigger picture remains mixed, weekly breadth is still tilted to decliners and the 3-month ledger remains slightly negative, suggesting this rebound needs follow-through to become a durable trend.
After Wednesday’s heavy selling, Thursday delivered a clear breadth rebound: advancers retook control and the “big down” day count normalized. But zooming out, the market is still working through short-term damage, weekly breadth remains skewed to decliners and the major ETFs are still battling key moving averages and overhead supply.
Wednesday’s pullback wasn’t just an index dip, participation weakened materially. Daily and weekly breadth flipped decisively bearish, breakouts dried up, and a growing chunk of stocks slipped back under short-term moving averages. Longer-term trend structure is still intact, but the tape is starting to feel more like “distribution” than “healthy digestion.”
Tuesday’s session kept the headline indexes relatively contained, but internal participation continued to soften. The S&P 500 and Nasdaq remain in short-term pullback mode below their fast moving averages, while small caps are busy retesting a key breakout zone. Longer-term trends are still constructive, yet the breadth “engine” is clearly running less efficiently than it did earlier in December.
Major ETFs are still holding key support on the weekly timeframe, but participation under the surface continues to fade. Monday’s session showed a still-negative advance/decline split and a noticeable rise in “hard down” movers (>4%), while fewer stocks remain above short-term moving averages. The tape is not breaking yet, but it’s getting thinner.
